logo
calendar26 Iyul 2025
view26
Основной язык:Английский

ВАРИАЦИИ ГУМОРАЛЬНОГО ИММУНИТЕТА ПРИ МИГРЕНИ У ДЕТЕЙ И ПОДРОСТКОВ

Область науки:
pdf

6884a52d931ea.pdf

PDF

АННОТАЦИЯ СТАТЬИ

quote
Migraine in children and adolescents is increasingly being recognized not only as a neurological disorder, but also as a condition with possible immune system involvement. This paper explores the role of humoral immunity in the pathogenesis and clinical presentation of pediatric migraine. Based on the study of 42 children aged 6 to 18 with various forms of migraine, significant differences in immunoglobulin levels and circulating immune complexes (CIC) were observed. These findings suggest the presence of immune imbalance in children with migraines, especially those with aura. Understanding the immunological aspects of migraine can contribute to improved diagnostics, prognostics, and the development of personalized therapeutic strategies

АВТОРЫ

N.Kodirova

Tashkent Pediatric Medical Institute, Uzbekistan

Теги

# circulating immune complexes# immunoglobulin G# humoral immunity# Pediatric migraine# immunoglobulin M# immune imbalance# migraine with aura# immunopathogenesis

ДРУГИЕ СТАТЬИ ЭТОГО ЖУРНАЛА

Оценить статью

0
оценок: 0
5
4
3
2
1

Идентификаторы статьи

DOI:

Недоступно

Список литературы

1.Khaitov, P.M., Pinegin B.V., YarilinA.A. Manual of Clinical Immunology: Diagnosis of Diseases of the Immune System. Moscow: GEOTAR-Media, 2009. 352 p.2.Shamansurov Sh.Sh., Gulyamova M.K., Karimova N.A. Basilar migraine in children -an object of diagnostic error. NEVROLOGIYA. 2014; 2(58): 101.3.Hermann G.E., Holmes G.M., Rogers R.S. TNF(α) modulation of visceral and spinal sensory processing. Curr Pharm Des. 2005;11(11):1391–14094.Gazerani P. et al. The role of immune and inflammatory mechanisms in migraine. J Headache Pain. 2019; 20:122. doi:10.1186/s10194-019-1069-1.5.Alstadhaug K.B. Migraine and the immune system. J Neurol Sci. 2014; 344(1–2): 3–7. doi:10.1016/j.jns.2014.06.028.6.Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018; 17(2): 174–182. doi:10.1016/S1474-4422(17)30435-0.